4L2-22670-75639
2 vaccinations
5 coded responses
22 check-ins
5 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 315 / GA
- Registered
- 2021-04-17
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-16
Dose 1 — Pfizer-BioNTech
-
2021-04-17
Registered in v-safe
-
2021-04-17
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Fatigue or tirednessAdult check-in
-
2021-04-18
Survey response — days 1–6 daily, dose 1MedDRA: Polymenorrhoea — Feeling: Good · Site: Pain, ItchingFree text: Menstruation stopped midcycle/day three.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-19
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-30
-
2021-05-10
Dose 2 — Pfizer-BioNTech
- 2021-05-10
-
2021-05-11
Survey response — days 1–6 daily, dose 2MedDRA: Sleep terror — Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tirednessFree text: Night terrorsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Joint pains, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2021-05-13
- 2021-05-14
- 2021-05-15
- 2021-05-17
-
2021-05-24
Survey response — day 14, dose 2MedDRA: Heavy menstrual bleeding — Feeling: GoodFree text: Prolonged menstruation over the course of ten days.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-01
- 2021-06-07
-
2021-06-16
Survey response — day 35, dose 2MedDRA: Pregnancy test positive — Feeling: GoodFree text: Positive pregnancy testMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-06-21
-
2021-08-09
Survey response — 3 months, dose 2MedDRA: Abortion spontaneous, Haemorrhage — Feeling: Poor · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: Miscarriage of pregnancy, hemorrhaging.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-09
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-08-12
-
2021-08-16
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
- 2021-11-08
- 2022-05-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-16 | Pfizer-BioNTech | |
| 2 | 2021-05-10 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-08-09 | Successful 2021-08-16 |
Not applicable (accidental reporting or does not believe symptoms are related to vaccine) |
Free text
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Menstruation stopped midcycle/day three.
Release 8 — days 1–6 daily, dose 2
Systemic reaction (other): Night terrors
Release 8 — day 14, dose 2
Symptoms: Prolonged menstruation over the course of ten days.
Release 9 — day 35, dose 2
Symptoms: Positive pregnancy test
Release 9 — 3 months, dose 2
Symptoms: Miscarriage of pregnancy, hemorrhaging.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abortion spontaneous | ✓ | · | ✓ |
| SD | Haemorrhage | ✓ | · | ✓ |
| SD | Heavy menstrual bleeding | ✓ | ✓ | ✓ |
| SD | Pregnancy test positive | ✓ | ✓ | ✓ |
| SRO | Polymenorrhoea | ✓ | ✓ | ✓ |
| SRO | Sleep terror | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release